2019
DOI: 10.1016/j.rehab.2017.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews

Abstract: Despite the available range of non-pharmacological interventions for spasticity, there is lack of high-quality evidence for many modalities. Further research is needed to judge the effect with appropriate study designs, timing and intensity of modalities, and associate costs of these interventions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
56
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 92 publications
(61 citation statements)
references
References 45 publications
2
56
0
3
Order By: Relevance
“…). The results of this review agree with the findings of other reviews which also conclude that there is a lack of high quality evidence for many modalities of treatment of spasticity (Khan, Amatya, Bensmail, & Yelnik, 2017).…”
Section: What Are the Implications Of The Cochrane Evidence For Practsupporting
confidence: 87%
“…). The results of this review agree with the findings of other reviews which also conclude that there is a lack of high quality evidence for many modalities of treatment of spasticity (Khan, Amatya, Bensmail, & Yelnik, 2017).…”
Section: What Are the Implications Of The Cochrane Evidence For Practsupporting
confidence: 87%
“…The therapeutic effect or mechanism of action of EA for myotonia in DM1 has not been reported. However, EA is widely used as a non-pharmacological intervention for spasticity, [ 16 ] and EA is known to affect muscle hyper-excitability. In a previous post-stroke spasticity study, acupuncture increased the mean H-reflex recovery time within the antagonistic muscle of the spastic muscle.…”
Section: Discussionmentioning
confidence: 99%
“…A variety of pharmacological and non-pharmacological treatments are available for the control of severe spasticity[ 9 ]. However, there is no high-quality evidence for non-pharmacological treatments; hence, pharmacological treatment is favored over non-pharmacological treatment[ 9 , 10 ]. Oral baclofen is generally recommended as first line treatment for spasticity in individuals with SCI[ 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, there is no high-quality evidence for non-pharmacological treatments; hence, pharmacological treatment is favored over non-pharmacological treatment[ 9 , 10 ]. Oral baclofen is generally recommended as first line treatment for spasticity in individuals with SCI[ 9 , 10 ]. However, the relatively high oral doses of baclofen have been associated with undesirable side effects such as dizziness, fatigue, liver toxicity and excessive sedation, which can impair problem solving and intellectual judgement[ 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%